";s:4:"text";s:4319:"In patients with PAH, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation.Studies in vitro have shown that sildenafil is selective for PDE-5. No evaluation of the quality of this assessment has been made for the HTA database.All Wales Medicines Strategy Group (AWMSG). (See Figure D)5. Do not use sildenafil for oral suspension for a condition for which it was not prescribed. This effect was not seen in idiopathic PAH (sildenafil 3%, placebo 2%) patients. If you would like more information about sildenafil for oral suspension talk with your doctor. A 2mL oral dosing syringe (with 0.5mL and 2mL dose markings) and a press-in bottle adaptor are also provided. Visual disturbances were identified as mild and transient, and were predominately color-tinge to vision, but also increased sensitivity to light or blurred vision.The incidence of retinal hemorrhage with sildenafil 20 mg three times a day was 1.4% versus 0% placebo and for all sildenafil doses studied was 1.9% versus 0% placebo. Bioequivalence has been established between the 20-mg tablet and the 10-mg/mL oral suspension when administered as a single oral dose of 20 mg. Adverse reactions were generally transient and mild to moderate in nature.At doses higher than the recommended 20 mg three times a day, there was a greater incidence of some adverse reactions including flushing, diarrhea, myalgia and visual disturbances. Take with or without food. The study population consisted of 25% men and 75% women with a mean age of 49 years (range: 18 years to 81 years) and baseline 6-minute walk distance between 100 meters and 450 meters (mean 343).The primary efficacy endpoint was the change from baseline at week 12 (at least 4 hours after the last dose) in the 6-minute walk distance. For more information call Ajanta Pharma USA Inc. at 855-664-7744.This Patient Information has been approved by the U.S. Food and Drug AdministrationAll other trademark names are the property of their respective owners.Read this Instructions for Use for sildenafil for oral suspension before you start taking and each time you get a refill. This information does not take the place of talking with your doctor about your medical condition or treatment. Turn the bottle back upright with the oral syringe still in place. The effect of sildenafil on epoprostenol pharmacokinetics is not known.No significant interactions were shown with tolbutamide (250 mg) or warfarin (40 mg), both of which are metabolized by CYP2C9.Sildenafil (50 mg) did not potentiate the hypotensive effect of alcohol in healthy volunteers with mean maximum blood alcohol levels of 0.08%.Sildenafil was not carcinogenic when administered to rats for up to 24 months at 60 mg/kg/day, a dose resulting in total systemic exposure (AUC) to unbound sildenafil and its major metabolite 33- and 37- times, for male and female rats respectively, the human exposure at the RHD of 20 mg three times a day. Sildenafil (Revatio®) 10mg/ml powder for oral suspension is recommended as an option for use within NHS Wales for the treatment of paediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension. What is this medicine? If priapism (painful erection greater than 6 hours in duration) is not treated immediately, penile tissue damage and permanent loss of potency could result.In a small, prematurely terminated study of patients with pulmonary hypertension (PH) secondary to sickle cell disease, vaso-occlusive crises requiring hospitalization were more commonly reported by patients who received sildenafil for oral suspension than by those randomized to placebo. Sildenafil (Revatio) 10mg/ml powder for oral suspension. Sildenafil exposure at a dose of 80 mg three times a day without concomitant medication is shown to be 5-fold the exposure at a dose of 20 mg three times a day.